Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -7.35M | -154.69% | $ 4.75M |
3/31/2025 | $ -4.93M | -69.02% | $ 7.15M |
12/31/2024 | $ -5.18M | -52.99% | $ 9.78M |
9/30/2024 | $ -4.53M | -40.41% | $ 11.2M |
6/30/2024 | $ -2.83M | -23.51% | $ 12.02M |
3/31/2024 | $ -4.09M | -28.75% | $ 14.23M |
12/31/2023 | $ -4.13M | -28.05% | $ 14.73M |
9/30/2023 | $ -5.03M | -34.33% | $ 14.64M |
6/30/2023 | $ -6.35M | -41.78% | $ 15.2M |
3/31/2023 | $ -6.21M | -45.52% | $ 13.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NOVABAY PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -4.71M ] / Revenues [ $ 9.75M ]
(=) OCF % [ -48.26% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |